Tyrus Capital S.A.M.’s Pfizer PFE Stock Holding History

Tyrus Capital S.A.M.’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,581,000	Closed	-$44.5M	–	41
2016 Q1	$44.5M	Buy	1,581,000 +1,560,624	+7,659%	+$44.6M	7.57%	4
2015 Q4	$624K	Buy	+20,376	New	+$641K	0.15%	20
2015 Q1	–	Sell	-2,271,370	Closed	-$67.1M	–	34
2014 Q4	$67.1M	Buy	2,271,370 +885,360	+64%	+$25.4M	11.82%	2
2014 Q3	$38.9M	Buy	1,386,010 +642,940	+87%	+$18M	6.47%	10
2014 Q2	$20.9M	Sell	743,070 -158,100	-18%	-$4.51M	2.75%	17
2014 Q1	$27.5M	Sell	901,170 -2,053,903	-70%	-$61.2M	5.57%	11
2013 Q4	$85.9M	Buy	2,955,073 +2,586,173	+701%	+$75.3M	32.76%	1
2013 Q3	$10.1M	Buy	+368,900	New	+$10M	2.91%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tyrus Capital S.A.M.'s PFE Position: Q2 2016 in Review

Tyrus Capital S.A.M. sold out of Pfizer (PFE) in Q2 2016, closing a stake of 1,581,000 shares — an estimated $44.5M sold.

Tyrus Capital S.A.M. first reported a position in PFE in Q3 2013 and held it in 8 quarters. The position peaked at $85.9M in Q4 2013. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Tyrus Capital S.A.M. reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Tyrus Capital S.A.M. sold 1,581,000 Pfizer shares in Q2 2016, an estimated $44.5M.
Tyrus Capital S.A.M. first reported a position in Pfizer in Q3 2013 and held it in 8 quarters.
Tyrus Capital S.A.M.'s Pfizer position peaked at $85.9M in Q4 2013.
1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Tyrus Capital S.A.M.'s 13F filing for Q2 2016, filed 15 Aug 2016.